 |
|
|
|
|
|
|
| Article 1 to 10 out of 34 concerning Eli Lilly and Company
|
-
Evonik completes acquisition of Tippecanoe Laboratories in USA
(08 Jan 2010)
Evonik Industries AG has completed the purchase of the Tippecanoe Laboratories manufacturing facility in Lafayette (Indiana, USA) from Eli Lilly and Company, Indianapolis (USA). The deal was closed on January 1, 2010. It was agreed not to disclose ...
-
Evonik strengthens its exclusive synthesis business in US
(21 Oct 2009)
Evonik acquires Eli Lilly and Company’s U.S. Tippecanoe manufacturing site
Evonik Industries AG has agreed to acquire Indianapolis, Indiana-based Eli Lilly and Company’s Tippecanoe Laboratories manufacturing facility in Lafayette, Indiana. The site, which employs about 700, manufactures active pharmaceutical ingredients ...
-
Chemists synthesize herbal alkaloid
(20 Apr 2009)
The club moss Lycopodium serratum is a creeping, flowerless plant used in homeopathic medicine to treat a wide variety of ailments. It contains a potent brew of alkaloids that have attracted considerable scientific and medical interest. However, the ...
-
Scandal in the Pharmaceutical World
(30 Jun 2008)
A large number of the world's largest pharmaceutical companies have illegally used, and profited from, a groundbreaking patent stolen from Nogdan Immunochemicals Ltd., an Israeli biotech company
Nogdan Immunochemicals Ltd.and Mr. Roland Taieb, the exclusive owner of the patent's marketing rights worldwide, announced that many of the world's largest pharmaceutical companies are embroiled in the legal dispute concerning their groundbreaking ...
-
CMC Acquires Former ICOS Biologics Operation in Bothell, Washington State, USA
(05 Dec 2007)
CMC Biopharmaceuticals to purchase facility from Lilly; will retain existing employees
CMC Biopharmaceuticals A/S (CMC) announced that it has reached an agreement to buy the biologics development and manufacturing operation that Eli Lilly and Company acquired when it purchased ICOS Corporation in January 2007. CMC, a Copenhagen based ...
-
Lilly Announces New Employee Policy
(11 May 2007)
Privacy and protection of genetic information essential for improved patient care
Eli Lilly and Company announced an expansion of its employee policies to include protection of genetic information. This addition to Lilly's privacy and nondiscrimination policies ensures an employee's genetic information cannot be used to ...
-
Lilly Announces Acquisition of Hypnion
(07 Mar 2007)
Deal shall bolster Lilly's Sleep Disorder Research with promising insomnia compound
Eli Lilly and Company and Hypnion, Inc. announced that they have signed a definitive merger agreement whereby Lilly will acquire Hypnion, a privately held neuroscience drug discovery company focused on sleep disorders. The transaction has received ...
-
ICOS Shareholders Vote to Approve Merger With Eli Lilly
(29 Jan 2007)
ICOS Corporation (ICOS) announced that its shareholders approved the revised Agreement and Plan of Merger whereby Eli Lilly and Company will acquire all of the outstanding stock of ICOS for a purchase price of $34 per share in cash.There was a ...
-
Alkermes and Lilly Expand AIR Inhaled Insulin Collaboration
(10 Jan 2007)
Alkermes, Inc. and Eli Lilly and Company announced that they have signed a commercial manufacturing agreement for AIR® Inhaled Insulin (AIR® Insulin). As a result of the agreement, Alkermes will be the exclusive commercial manufacturer of AIR ...
-
ICOS Announces Revised Merger Agreement With Lilly
(20 Dec 2006)
ICOS Corporation announced that an agreement has been reached to amend the terms of the merger agreement with Eli Lilly and Company, which was originally signed on October 16, 2006. The revised Agreement and Plan of Merger provides that Lilly will ...
|
|
|
|
|
Top
